[1]
S. Chiorescu, O. A. Andercou, N. O. Grad, and I. A. Mironiuc, “Intraperitoneal Administration of Rosuvastatin Prevents Postoperative Peritoneal Adhesions by Decreasing the Release of Tumor Necrosis Factor”, Med Pharm Rep, vol. 91, no. 1, pp. 79–84, Jan. 2018.